Literature DB >> 25971390

Endogenous IgG hypogammaglobulinaemia in critically ill adults with sepsis: systematic review and meta-analysis.

Manu Shankar-Hari1, Nicholas Culshaw, Benjamin Post, Eduardo Tamayo, David Andaluz-Ojeda, Jesús F Bermejo-Martín, Sebastian Dietz, Karl Werdan, Richard Beale, Jo Spencer, Mervyn Singer.   

Abstract

PURPOSE: Plasma immunoglobulin concentrations are acutely altered in critically ill patients with sepsis. However, the association between immunoglobulin levels on the day of sepsis diagnosis and subsequent mortality is inconsistent.
METHODS: Systematic review of studies that report immunoglobulin measurements and mortality among adults with sepsis managed in a critical care setting. Fixed and random effect meta-analyses were conducted using low IgG levels as primary exposure and acute mortality as the primary outcome. Both variables were used as defined in individual studies.
RESULTS: The prevalence of a low immunoglobulin G (IgG) concentration on the day of sepsis diagnosis was variable [58.3% (IQR 38.4-65.5%)]. Three cut-off points (6.1, 6.5 and 8.7 g/L) were used to define the lower limit of IgG concentrations in the included studies. A subnormal IgG level on the day of sepsis diagnosis was not associated with an increased risk of death in adult patients with severe sepsis and/or septic shock by both fixed and random effect meta-analysis (OR [95% CI] 1.32 [0.93-1.87] and 1.48 [0.78-2.81], respectively).
CONCLUSIONS: This systematic review identifies studies of limited quality reporting heterogeneous sepsis cohorts with varying lower limits of normal for IgG. Although our data suggest that a subnormal IgG measurement on the day of sepsis diagnosis does not identify a subgroup of patients with a higher risk of death, further studies are needed to confirm or refute this finding, and whether optimal cut-offs and time windows can be defined for IgG measurement. This would determine whether patients receiving intravenous immunoglobulin therapy for sepsis could be stratified using IgG levels.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25971390     DOI: 10.1007/s00134-015-3845-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  32 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Sepsis and endothelial permeability.

Authors:  Warren L Lee; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

Review 3.  Biomarkers and surrogate end points--the challenge of statistical validation.

Authors:  Marc Buyse; Daniel J Sargent; Axel Grothey; Alastair Matheson; Aimery de Gramont
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 5.  The new normal: immunomodulatory agents against sepsis immune suppression.

Authors:  Noelle A Hutchins; Jacqueline Unsinger; Richard S Hotchkiss; Alfred Ayala
Journal:  Trends Mol Med       Date:  2014-01-30       Impact factor: 11.951

6.  Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly.

Authors:  Shigeaki Inoue; Kyoko Suzuki-Utsunomiya; Yoshinori Okada; Takayuki Taira; Yumi Iida; Naoya Miura; Tomoatsu Tsuji; Takeshi Yamagiwa; Seiji Morita; Tomoki Chiba; Takehito Sato; Sadaki Inokuchi
Journal:  Crit Care Med       Date:  2013-03       Impact factor: 7.598

7.  Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis.

Authors:  J F Bermejo-Martín; A Rodriguez-Fernandez; R Herrán-Monge; D Andaluz-Ojeda; A Muriel-Bombín; P Merino; M M García-García; R Citores; F Gandía; R Almansa; J Blanco
Journal:  J Intern Med       Date:  2014-05-29       Impact factor: 8.989

8.  Immunotherapy improves immune homeostasis and increases survival rate of septic patients.

Authors:  Shun-wei Huang; Juan Chen; Bin Ouyang; Chun-hua Yang; Min-ying Chen; Xiang-dong Guan
Journal:  Chin J Traumatol       Date:  2009-12

9.  A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis.

Authors:  Jonathan S Boomer; Jennifer Shuherk-Shaffer; Richard S Hotchkiss; Jonathan M Green
Journal:  Crit Care       Date:  2012-06-28       Impact factor: 9.097

10.  Early natural killer cell counts in blood predict mortality in severe sepsis.

Authors:  David Andaluz-Ojeda; Verónica Iglesias; Felipe Bobillo; Raquel Almansa; Lucía Rico; Francisco Gandía; Ana Ma Loma; Concepción Nieto; Rosa Diego; Epifanio Ramos; Mercedes Nocito; Salvador Resino; Jose M Eiros; Eduardo Tamayo; Raul Ortiz de Lejarazu; Jesús F Bermejo-Martin
Journal:  Crit Care       Date:  2011-10-21       Impact factor: 9.097

View more
  21 in total

Review 1.  Immunoglobulins and sepsis.

Authors:  Manu Shankar-Hari; Martin Bruun Madsen; Alexis F Turgeon
Journal:  Intensive Care Med       Date:  2018-01-18       Impact factor: 17.440

2.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

3.  Follicular dendritic cell dysfunction contributes to impaired antigen-specific humoral responses in sepsis-surviving mice.

Authors:  Minakshi Rana; Andrea La Bella; Rivka Lederman; Bruce T Volpe; Barbara Sherry; Betty Diamond
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

4.  Serum IgG levels and mortality in patients with severe sepsis and septic shock : The SBITS data.

Authors:  S Dietz; C Lautenschläger; U Müller-Werdan; G Pilz; P Fraunberger; M Päsler; H Ebelt; A K Walli; K Werdan; S Nuding
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-09-27       Impact factor: 0.840

5.  Victims or Culprits, B Cells May Serve as Markers for Mortality Risk and Targeted Therapy in Sepsis.

Authors:  Zoltán Spolarics
Journal:  Crit Care Med       Date:  2017-11       Impact factor: 7.598

Review 6.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

7.  The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure.

Authors:  Ignacio Martin-Loeches; Arturo Muriel-Bombín; Ricard Ferrer; Antonio Artigas; Jordi Sole-Violan; Leonardo Lorente; David Andaluz-Ojeda; Adriele Prina-Mello; Ruben Herrán-Monge; Borja Suberviola; Ana Rodriguez-Fernandez; Pedro Merino; Ana M Loza; Pablo Garcia-Olivares; Eduardo Anton; Eduardo Tamayo; Wysali Trapiello; Jesús Blanco; Jesús F Bermejo-Martin
Journal:  Ann Intensive Care       Date:  2017-04-20       Impact factor: 6.925

Review 8.  New aspects in the management of pneumonia.

Authors:  Elena Prina; Adrian Ceccato; Antoni Torres
Journal:  Crit Care       Date:  2016-10-01       Impact factor: 9.097

9.  Should we consider IgG hypogammaglobulinemia a risk factor for severe complications of Ludwig angina?: A case report and review of the literature.

Authors:  Orville V Baez-Pravia; Miriam Díaz-Cámara; Oscar De La; Carlos Pey; Mercedes Ontañón Martín; Luis Jimenez Hiscock; Begoña Morató Bellido; Ángel Luis Córdoba Sánchez
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

10.  Low Levels of Immunoglobulins and Mannose-Binding Lectin Are Not Associated With Etiology, Severity, or Outcome in Community-Acquired Pneumonia.

Authors:  William W Siljan; Jan C Holter; Ståle H Nymo; Einar Husebye; Thor Ueland; Lillemor Skattum; Vidar Bosnes; Peter Garred; Stig S Frøland; Tom E Mollnes; Pål Aukrust; Lars Heggelund
Journal:  Open Forum Infect Dis       Date:  2018-01-05       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.